South Korea
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.28 B
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
2 |
USD 412.54 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
3 |
USD 244.35 M
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
4 |
USD 166.30 M
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
5 |
USD 157.94 M
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
6 |
USD 121.88 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
7 |
USD 110.69 M
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
8 |
USD 101.81 M
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
9 |
USD 76.77 M
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
10 |
USD 72.91 M
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
11 |
USD 69.34 M
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
12 |
USD 66.94 M
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
13 |
USD 39.73 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
14 |
USD 37.87 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
15 |
USD 32.43 M
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
16 |
USD 32.10 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
17 |
USD 29.71 M
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
18 |
USD 28.53 M
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
19 |
USD 27.63 M
|
Dec. 31, 2023 | USD 7.87 | -2.10% |
|
South Korea |
|
20 |
USD 27.00 M
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
21 |
USD 26.34 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
22 |
USD 22.54 M
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
23 |
USD 22.40 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
24 |
USD 20.31 M
|
Dec. 31, 2023 | USD 8.83 | 4.03% |
|
South Korea |
|
25 |
USD 17.82 M
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
26 |
USD 10.38 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
27 |
USD 10.25 M
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
28 |
USD 9.07 M
|
Dec. 31, 2023 | USD 5.00 | -8.15% |
|
South Korea |
|
29 |
USD 9.02 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
30 |
USD 8.40 M
|
Dec. 31, 2023 | USD 3.22 | 0.07% |
|
South Korea |
|
31 |
USD 6.64 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
32 |
USD 6.40 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
33 |
USD 5.87 M
|
Dec. 31, 2023 | USD 9.81 | -0.42% |
|
South Korea |
|
34 |
USD 5.29 M
|
Dec. 31, 2023 | USD 4.14 | -7.03% |
|
South Korea |
|
35 |
USD 5.17 M
|
Dec. 31, 2023 | USD 1.89 | -1.74% |
|
South Korea |
|
36 |
USD 4.18 M
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
37 |
USD 4.18 M
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
38 |
USD 3.18 M
|
Dec. 31, 2023 | USD 11.53 | -7.22% |
|
South Korea |
|
39 |
USD 3.00 M
|
Dec. 31, 2023 | USD 1.18 | -3.42% |
|
South Korea |
|
40 |
USD 2.75 M
|
Dec. 31, 2023 | USD 3.25 | -3.09% |
|
South Korea |
|
41 |
USD 2.59 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
42 |
USD 2.39 M
|
Dec. 31, 2023 | USD 3.75 | -3.31% |
|
South Korea |
|
43 |
USD 1.39 M
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
44 |
USD 997.16 K
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
45 |
USD 323.22 K
|
Dec. 31, 2023 | USD 3.01 | -3.95% |
|
South Korea |
|
46 |
USD -1.53 M
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
|
47 |
USD -3.78 M
|
Dec. 31, 2023 | USD 0.29 | -4.87% |
|
South Korea |
|
48 |
USD -3.98 M
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
49 |
USD -4.20 M
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
50 |
USD -4.61 M
|
Dec. 31, 2023 | USD 8.66 | -7.96% |
|
South Korea |
The Healthcare company in South Korea with the highest Operating Cash Flow is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 1.28 B.
The Healthcare company in South Korea with the lowest Operating Cash Flow is SD BioSensor, Inc (KSE: 137310.KS) at USD -186.10 M.
The top 10 Healthcare companies in South Korea by Operating Cash Flow are Samsung Biologics Co.,Ltd., Celltrion, Inc., Chong Kun Dang Pharmaceutical Corp., Hanmi Pharm. Co., Ltd., Daewoong Co., Ltd., Dong-A Socio Holdings Co., Ltd., Yuhan Corporation, Daewoong pharmaceutical Co.,Ltd, Huons Global Co., Ltd. and Seegene, Inc..
The bottom 10 Healthcare companies in South Korea by Operating Cash Flow are SD BioSensor, Inc, SK Biopharmaceuticals Co., Ltd., Ilsung Pharmaceuticals Co., Ltd., Green Cross Holdings Corporation, Genexine, Inc., Aprogen pharmaceuticals,Inc., CrystalGenomics, Inc., ABL Bio Inc., SAMSUNG PHARM. Co., LTD. and MedPacto, Inc..